Found: 5
Select item for more details and to access through your institution.
RAS and BRAF mutations in cell‐free DNA are predictive for outcome of cetuximab monotherapy in patients with tissue‐tested RAS wild‐type advanced colorectal cancer.
- Published in:
- Molecular Oncology, 2019, v. 13, n. 11, p. 2361, doi. 10.1002/1878-0261.12550
- By:
- Publication type:
- Article
A clinicopathological study and prognostic factor analysis of 177 salivary duct carcinoma patients from The Netherlands.
- Published in:
- International Journal of Cancer, 2018, v. 143, n. 4, p. 758, doi. 10.1002/ijc.31353
- By:
- Publication type:
- Article
Androgen deprivation therapy for androgen receptor‐positive advanced salivary duct carcinoma: A nationwide case series of 35 patients in The Netherlands.
- Published in:
- Head & Neck, 2018, v. 40, n. 3, p. 605, doi. 10.1002/hed.25035
- By:
- Publication type:
- Article
Impact of chemotherapy on the outcome of osteosarcoma of the head and neck in adults.
- Published in:
- Head & Neck, 2017, v. 39, n. 1, p. 140, doi. 10.1002/hed.24556
- By:
- Publication type:
- Article
Lesion detection by [<sup>89</sup>Zr]Zr-DFO-girentuximab and [<sup>18</sup>F]FDG-PET/CT in patients with newly diagnosed metastatic renal cell carcinoma.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 9, p. 1931, doi. 10.1007/s00259-019-04358-9
- By:
- Publication type:
- Article